Media Coverage
MarketWatch
The dark side of the weight-loss-drug craze: eating disorders, medication shortages, dangerous knockoffs
In this piece, Dr. Elizabeth Wassenaar shares insight with MarketWatch about the dangers of GLP-1 medications and their impact to the eating disorder community and especially adolescents. Dr. Wassenaar shared: “The adolescent mental health crisis is unprecedented,” said Wassenaar, with many teens suffering severe mood disorders, eating disorders, and suicidality, and teens struggling with depression may think, 'If I lose weight, I’ll feel better and people will like me. There’s this magic drug, and all I have to do is inject it.'” And if patients can start taking these drugs as early as 12 years of age, “We just don’t know what that’s going to do to them in 10 or 20 years,” she said, because there’s not enough long-term data.